Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Drug Targets, Volume 22 - Number 2


Review Article (Mini-Review)

Medicinal Plants Towards Modeling Skin Cancer

, 22(2): 148 - 161

Mohammad El-Harakeh, Sara Al-Ghadban and Rémi Safi*


DOI: 10.2174/1389450121666201005103521



Review Article (Mini-Review)

PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives

, 22(2): 162 - 170

Thomas Gevaert*, Alessia Cimadamore, Rodolfo Montironi and Markus Eckstein


DOI: 10.2174/1389450121666200510015216



Review Article


Review Article

Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression

, 22(2): 183 - 191

Shvetank Bhatt*, Jovita Kanoujia, Arghya Kusum Dhar, Surendar Arumugam, Amanda K. A. Silva and Neeraj Mishra


DOI: 10.2174/1389450121999201006193005



Review Article

Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion

, 22(2): 192 - 201

Upinder Kaur, Sankha Shubhra Chakrabarti*, Bisweswar Ojha, Bhairav Kumar Pathak, Amit Singh, Luciano Saso and Sasanka Chakrabarti


DOI: 10.2174/1389450121666200924113243



Review Article

Prognostic Parameters in Myeloid Malignancies in a Historical Context – From Microscopy to Individualized Medicine

, 22(2): 202 - 213

Paul Jäger*, Sören Twarock and Rainer Haas


DOI: 10.2174/1389450121666201001122816



Review Article

Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling

, 22(2): 214 - 240

Shilpi Agrawal, Sanhita Maity, Zeina AlRaawi, Musaab Al-Ameer and Thallapuranam Krishnaswamy Suresh Kumar*


DOI: 10.2174/1389450121999201012201926



Review Article

Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors

, 22(2): 241 - 251

Riccardo Mager, Giulia Roda, Mohammad Khaled Shalaby and Stefania Vetrano*


DOI: 10.2174/1389450121666201020160803




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 5.5

Related Journals

Related eBooks

eBooks Catalog